Get started
Author

Paul E. Mallet

Observed names: Mallet, Paul, Mallet, Paul E, Mallet, Paul E., Mallet, Paul Emile, P MALLET, P. E. Mallet, P.E. Mallet, PAUL E. MALLET, Paul E Mallet, Paul E. Mallet C
Observed institutions: The University of Sydney, Queen's University, University of New England, University of Windsor, Wilfrid Laurier University, University of New England
ORCID: 0000-0003-3358-4180
Observed ORCID: 0000-0003-3358-4180
OpenAlex ID: A5012761158
Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats
2004 · Melanie O'Shea, Malini E. Singh, et al. · Journal of Psychopharmacology · 293
Adolescent Rats Find Repeated Δ9-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure
2007 · Heidi R Quinn, Izuru Matsumoto, et al. · Neuropsychopharmacology · 291
Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist
1999 · Jason E. Gallate, Tanya Saharov, et al. · European Journal of Pharmacology · 235
Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats
2006 · Melanie O'Shea, Iain S. McGregor, et al. · Journal of Psychopharmacology · 231
The cannabinoid CB 1 receptor antagonist SR141716A attenuates the memory impairment produced by ? 9 -tetrahydrocannabinol or anandamide
1998 · P. E. Mallet, R. J. Beninger · Psychopharmacology · 178
Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (“Ecstasy”)
2001 · Kirsten C Morley, Jason E Gallate, et al. · European Journal of Pharmacology · 137
Δ9-Tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance
1998 · Paul E. Mallet, Richard J. Beninger · Life Sciences · 104
Evidence for an Interaction between CB1 Cannabinoid and Melanocortin MCR-4 Receptors in Regulating Food Intake
2004 · A. N. A. Verty, J. R. McFarlane, et al. · Endocrinology · 100
PDF
A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine
2004 · M.E. Singh, A.N.A. Verty, et al. · Brain Research · 85
The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain
2001 · Jonathon C Arnold, Ann N Topple, et al. · Brain Research · 77
Paraventricular hypothalamic CB1 cannabinoid receptors are involved in the feeding stimulatory effects of Δ9-tetrahydrocannabinol
2005 · Aaron N.A. Verty, Iain S. McGregor, et al. · Neuropharmacology · 72
Suppression of feeding, drinking, and locomotion by a putative cannabinoid receptor ‘silent antagonist’
2005 · Andrew Gardner, Paul E. Mallet · European Journal of Pharmacology · 66
Anxiety and aggression associated with the fermentation of carbohydrates in the hindgut of rats
2004 · T HANSTOCK, E CLAYTON, et al. · Physiology & Behavior · 66
The endogenous cannabinoid receptor agonist anandamide impairs memory in rats
1996 · P. E. Mallet, R. J. Beninger · Behavioural Pharmacology · 65
Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats
2003 · Christy S Norwood, Jennifer L Cornish, et al. · European Journal of Pharmacology · 63
Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake
2004 · A.N.A. Verty, J.R. McFarlane, et al. · Neuropharmacology · 62
A vapourized Δ9-tetrahydrocannabinol (Δ9-THC) delivery system part I: Development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents
2014 · Laurie A. Manwell, Armen Charchoglyan, et al. · Journal of Pharmacological and Toxicological Methods · 61
Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats
2004 · Kirsten C. Morley, Kong M. Li, et al. · Neuropharmacology · 59
Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats
2004 · Jason E. Gallate, Paul E. Mallet, et al. · Psychopharmacology · 56
A vapourized Δ9-tetrahydrocannabinol (Δ9-THC) delivery system part II: Comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents
2014 · Laurie A. Manwell, Brittany Ford, et al. · Journal of Pharmacological and Toxicological Methods · 54
Place conditioning with the dopamine D1-like receptor agonist SKF82958 but not SKF81297 or SKF77434
1998 · Brett S Abrahams, Jeff D Rutherford, et al. · European Journal of Pharmacology · 51
Perinatal Exposure to Δ9-Tetrahydrocannabinol Alters Heroin-Induced Place Conditioning and Fos-Immunoreactivity
2005 · Malini E Singh, Iain S McGregor, et al. · Neuropsychopharmacology · 50
The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol
2004 · Aaron N.A. Verty, Iain S. McGregor, et al. · Brain Research · 47
Δ9-thc Reinstates Beer- and Sucrose-seeking Behaviour in Abstinent Rats: Comparison With Midazolam, Food Deprivation and Predator Odour
2004 · IAIN S. McGREGOR, KRISTY D. B. DAM, et al. · Alcohol and Alcoholism · 46
Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716
2004 · M.E. Singh, A.N.A. Verty, et al. · Neuropharmacology · 45
Works count: 58
Citation count: 3,027
H-index: 31
I10-index: 39
Year
Topic
Type